Literature DB >> 12126313

Up-regulation of Hsp27 plays a role in the resistance of human colon carcinoma HT29 cells to photooxidative stress.

Hong P Wang1, John G Hanlon, Andrew J Rainbow, Myrna Espiritu, Gurmit Singh.   

Abstract

The Photofrin-resistant cell line (HT29-P14) was used in the present study to investigate the mechanism(s) involved in Photofrin-mediated photodynamic therapy (PDT). We compared gene expression profiles between the resistant cell line and its parental cell line (HT29) using DNA microarray analysis. A significant up-regulation of small heat shock protein 27 (Hsp27) was found in HT29-P14 cells. The elevated Hsp27 level may play an important role in the resistance of HT29-P14 to Photofrin-PDT. To test this hypothesis, we stably transfected HT29 cells with human Hsp27 complementary DNA. The potential role of Hsp27 in the resistance to PDT was examined in Hsp27-overexpressing cells. Stable trasnfected cells (H13) showed an increased survival after Photofrin-PDT, suggesting that the up-regulation of Hsp27 is related to the induced resistance to Photofrin-PDT. Phosphorylation of Hsp27 has been suggested to play an important role in cytoprotection. We have examined the phosphorylation activity of Hsp27 among the parental and resistant cells, as well as the overexpression cells. An elevated level of Hsp27 resulted in an increased ability of phosphorylation in both resistant and overexpressing cells after PDT. The activation of the phosphorylation of Hsp27 induced by PDT was not mediated by the p38 mitogen-activated protein kinase. These data suggest that Hsp27 may play an important role in mediating the adaptive response to Photofrin-PDT-induced oxidative stress and that the pathways leading to Hsp27 phosphorylation may contribute to the resistance of the cells to photooxidative damage.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12126313     DOI: 10.1562/0031-8655(2002)076<0098:urohpa>2.0.co;2

Source DB:  PubMed          Journal:  Photochem Photobiol        ISSN: 0031-8655            Impact factor:   3.421


  11 in total

1.  Expression and distribution of HSP27 in response to G418 in different human breast cancer cell lines.

Authors:  Lu Qian; Zhiyi Zhang; Ming Shi; Ming Yu; Meiru Hu; Qing Xia; Beifen Shen; Ning Guo
Journal:  Histochem Cell Biol       Date:  2006-05-30       Impact factor: 4.304

Review 2.  Tumor cell survival pathways activated by photodynamic therapy: a molecular basis for pharmacological inhibition strategies.

Authors:  Mans Broekgaarden; Ruud Weijer; Thomas M van Gulik; Michael R Hamblin; Michal Heger
Journal:  Cancer Metastasis Rev       Date:  2015-12       Impact factor: 9.264

Review 3.  Mechanisms of resistance to photodynamic therapy.

Authors:  A Casas; G Di Venosa; T Hasan
Journal:  Curr Med Chem       Date:  2011       Impact factor: 4.530

4.  Mechanisms in photodynamic therapy: part two-cellular signaling, cell metabolism and modes of cell death.

Authors:  Ana P Castano; Tatiana N Demidova; Michael R Hamblin
Journal:  Photodiagnosis Photodyn Ther       Date:  2005-03       Impact factor: 3.631

Review 5.  Photodynamic therapy of cancer: an update.

Authors:  Patrizia Agostinis; Kristian Berg; Keith A Cengel; Thomas H Foster; Albert W Girotti; Sandra O Gollnick; Stephen M Hahn; Michael R Hamblin; Asta Juzeniene; David Kessel; Mladen Korbelik; Johan Moan; Pawel Mroz; Dominika Nowis; Jacques Piette; Brian C Wilson; Jakub Golab
Journal:  CA Cancer J Clin       Date:  2011-05-26       Impact factor: 508.702

6.  Overexpression of heat shock factor 1 inhibits butyrate-induced differentiation in colon cancer cells.

Authors:  Jiyang Cai; Ward G Kirlin; Yan Chen; Xuexian Yan; Dean P Jones; Alan C Sartorelli
Journal:  Cell Stress Chaperones       Date:  2006       Impact factor: 3.667

7.  Proteasome inhibition potentiates antitumor effects of photodynamic therapy in mice through induction of endoplasmic reticulum stress and unfolded protein response.

Authors:  Angelika Szokalska; Marcin Makowski; Dominika Nowis; Grzegorz M Wilczynski; Marek Kujawa; Cezary Wójcik; Izabela Mlynarczuk-Bialy; Pawel Salwa; Jacek Bil; Sylwia Janowska; Patrizia Agostinis; Tom Verfaillie; Marek Bugajski; Jan Gietka; Tadeusz Issat; Eliza Glodkowska; Piotr Mrówka; Tomasz Stoklosa; Michael R Hamblin; Pawel Mróz; Marek Jakóbisiak; Jakub Golab
Journal:  Cancer Res       Date:  2009-05-12       Impact factor: 12.701

8.  Heme oxygenase-1 protects tumor cells against photodynamic therapy-mediated cytotoxicity.

Authors:  D Nowis; M Legat; T Grzela; J Niderla; E Wilczek; G M Wilczynski; E Głodkowska; P Mrówka; T Issat; J Dulak; A Józkowicz; H Waś; M Adamek; A Wrzosek; S Nazarewski; M Makowski; T Stokłosa; M Jakóbisiak; J Gołab
Journal:  Oncogene       Date:  2006-02-06       Impact factor: 9.867

9.  Protein microarray for complex apoptosis monitoring of dysplastic oral keratinocytes in experimental photodynamic therapy.

Authors:  Clara Matei; Mircea Tampa; Constantin Caruntu; Rodica-Mariana Ion; Simona-Roxana Georgescu; Georgiana Roxana Dumitrascu; Carolina Constantin; Monica Neagu
Journal:  Biol Res       Date:  2014       Impact factor: 5.612

10.  Multi-OMIC profiling of survival and metabolic signaling networks in cells subjected to photodynamic therapy.

Authors:  Ruud Weijer; Séverine Clavier; Esther A Zaal; Maud M E Pijls; Robert T van Kooten; Klaas Vermaas; René Leen; Aldo Jongejan; Perry D Moerland; Antoine H C van Kampen; André B P van Kuilenburg; Celia R Berkers; Simone Lemeer; Michal Heger
Journal:  Cell Mol Life Sci       Date:  2016-11-01       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.